[조사자료] 세계의 저분자 이노베이터 CDMO 시장 2024-2030 : 제품별 (저분자 API, 저분자 의약품), 단계별, 고객 유형별, 치료 영역별, 지역별

■ 영문 제목 : Small Molecule Innovator CDMO Market Size, Share & Trends Analysis Report By Product (Small Molecule API, Small Molecule Drug Product), By Stage Type, By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN134 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 119 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료 기기

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 저분자 이노베이터 CDMO 시장의 성장과 동향

Grand View Research, Inc.사의 최신 보고서에 따르면,세계의 저분자 이노베이터 CDMO 시장 규모는 2030년까지 749억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 6.21%의 성장률을 기록할 것으로 전망됩니다. 제약 기업들은 영업 및 마케팅과 같은 핵심 역량을 지원하기 위해 아웃소싱에 대한 관심이 높아지고 있습니다. 또한, 아웃소싱을 통해 의약품 개발 및 제조 활동과 같은 핵심 역량을 더욱 향상시킬 수 있습니다. 따라서 최근 저분자 CDMO의 사업 확장은 향후 몇 년 동안 시장 성장에 큰 도움이 될 것으로 예상됩니다.

저분자는 전 세계적으로 새로운 치료법 개발에 중요한 역할을 하고 있습니다. 특히 선진국 시장에서는 특수 의약품이 글로벌 의약품 제조의 성장을 주도하고 있으며, 특수 의약품 매출의 절반 이상을 저분자 응용 분야가 차지하고 있습니다. 저분자 응용은 점점 더 복잡해지고 있습니다.

규제 당국의 승인 파이프라인에 있는 대부분의 솔루션은 용해도가 낮은 화합물로 구성되어 있으며, 임상 시험과 그 이상의 단계로 나아가기 위해서는 활성화 기술이 필요합니다. 치료 목표와 중점 영역이 점점 더 구체화됨에 따라 타깃 제품 프로파일을 만드는 것이 점점 더 어려워지고 있습니다. 적절한 생체 이용률을 달성하지 못하는 것도 많은 신규 화합물 개발의 걸림돌이 되고 있습니다. 이러한 요인들이 전체 시장 성장을 뒷받침할 것으로 예상됩니다.

노인 인구는 향후 몇 년 동안 급증할 것으로 예상됩니다. 예를 들어, 세계보건기구(WHO)는 2050년까지 60세 이상 노인 인구가 20억 명을 넘어설 것으로 추정하고 있습니다. 이는 저분자 신약 개발에 큰 기회가 될 것이며, 팬데믹 이후 시장 성장을 뒷받침할 것으로 예상됩니다.

저분자 이노베이터 CDMO 시장 보고서 하이라이트

- 저분자 원료의약품 부문은 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 이러한 성장은 주로 규제 당국의 NME 저분자에 대한 높은 승인률에 기인합니다.

- 2023년 임상 단계 부문이 55.0%의 매출 점유율로 시장을 지배할 것으로 예상됩니다. CDMO는 임상 절차에 대한 전문 지식, 시간 절약 및 비용 효율성을 제공합니다. 따라서 예측 기간 동안 이 분야의 성장이 확대될 것으로 예상됩니다.

- 고객 유형별로는 제약사가 2023년 93.98%로 가장 큰 점유율을 차지할 것으로 예상됩니다. 제약사들이 판매와 같은 핵심 역량에 집중하고 CDMO가 저분자 의약품 생산에 대한 확장 전략을 채택하고 있는 것이 이 부문의 시장 성장을 촉진하고 있습니다.

- 암 분야는 2023년 42.09%의 매출 점유율로 시장을 지배하며 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 규제 당국의 승인 파이프라인에 있는 다수의 암 치료제가 이 분야의 성장을 이끄는 주요 요인 중 하나입니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 저분자 이노베이터 CDMO 시장 규모 : 변수, 동향 및 범위
4. 세계의 저분자 이노베이터 CDMO 시장 규모 : 제품별 세그먼트 분석
5. 세계의 저분자 이노베이터 CDMO 시장 규모 : 단계별 세그먼트 분석
6. 세계의 저분자 이노베이터 CDMO 시장 규모 : 고객 유형별 세그먼트 분석
7. 세계의 저분자 이노베이터 CDMO 시장 규모 : 치료 영역별 세그먼트 분석
8. 세계의 저분자 이노베이터 CDMO 시장 규모 : 지역별 분석
9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Stage Type
1.1.3 Customer Type
1.1.4 Therapeutic Area
1.1.5 Regional Scope
1.1.6 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Approaches Used To Estimate The Market Size
1.5.1.1 Approach 1: Region-Wise Market Estimation Using Bottom-Up Approach
1.5.1.2 Approach 2: Parent Market Analysis
1.5.1.3 Approach 3: Commodity Flow (Company Share Analysis)
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective – 1
1.9.2 Objective – 2
1.9.3 Objective – 3
1.9.4 Objective – 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Small Molecule Innovators CDMO Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Demand for Small Molecule Drug
3.2.1.2 Growing Demand for Small Molecules in the Oncology Segment
3.2.1.3 Increasing Pharmaceutical R&D Investments
3.2.2 Market Restraint Analysis
3.2.2.1 Stringent Government Regulations
3.3.2.2 Compliance Issues with Outsourcing
3.3 Small Molecule Innovators CDMO Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 PESTEL Analysis
3.4 Impact of COVID-19 and Reformation Strategies
Chapter 4 Small Molecule Innovator CDMO Market: Product Segment Analysis
4.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
4.2 Small Molecule API
4.2.1 Small Molecule API, 2018 – 2030 (USD Million)
4.3 Small Molecule Drug Product
4.3.1 Small Molecule Drug Product Market, 2018 – 2030 (USD Billion)
4.3.2 Oral Solid Dose
4.3.2.1 Oral Solid Dose Market, 2018 – 2030 (USD Billion)
4.3.3 Semi-Solid Dose
4.3.3.1 Semi-Solid Dose Market, 2018 – 2030 (USD Billion)
4.3.4 Liquid Dose
4.3.4.1 Liquid-Solid Dose Market, 2018 – 2030 (USD Billion)
4.3.5 Others
4.3.5.1 Others Market, 2018 – 2030 (USD Billion)
Chapter 5 Small Molecule Innovators CDMO Market: Stage Type Segment Analysis
5.1 Small Molecule Innovators Cdmo: Market Share Analysis, 2023 & 2030
5.2 Preclinical
5.2.1 Preclinical Market, 2018 – 2030 (USD Billion)
5.3 Clinical
5.3.1 Clinical Market, 2018 – 2030 (USD Billion)
5.3.2 Phase I
5.3.2.1 Phase I Market, 2018 – 2030 (USD Billion)
5.3.2.2 Small
5.3.2.2.1 Small Market, 2018 – 2030 (USD Billion)
5.3.2.3 Medium
5.3.2.3.1. Medium Market, 2018 – 2030 (USD Billion)
5.3.2.4 Large
5.3.2.4.1. Large Market, 2018 – 2030 (USD Billion)
5.3.3 Phase II
5.3.3.1 Phase II Market, 2018 – 2030 (USD Billion)
5.3.3.2 Small
5.3.3.2.1. Small Market, 2018 – 2030 (USD Billion)
5.3.3.3 Medium
5.3.3.3.1. Medium Market, 2018 – 2030 (USD Billion)
5.3.3.4 Large
5.3.3.4.1. Large Market, 2018 – 2030 (USD Billion)
5.3.4 Phase III
5.3.4.1 Phase III Market, 2018 – 2030 (USD Billion)
5.3.4.2 Small
5.3.4.2.1 Small Market, 2018 – 2030 (USD Billion)
5.3.4.3 Medium
5.3.4.3.1. Medium Market, 2018 – 2030 (USD Billion)
5.3.4.4 Large
5.3.4.4.1. Large Market, 2018 – 2030 (USD Billion)
5.4 Commercial
5.4.1. Commercial Market, 2018 – 2030 (USD Billion)
Chapter 6 Small Molecule Innovators CDMO Market: Customer Type Segment Analysis
6.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
6.2 Pharmaceutical
6.2.1 Pharmaceutical Market, 2018 – 2030 (USD Million)
6.2.2 Small
6.2.2.1 Small Market, 2018 – 2030 (USD Million)
6.2.3 Medium
6.2.3.1 Medium Market, 2018 – 2030 (USD Million)
6.2.4 Large
6.2.4.1 Large Market, 2018 – 2030 (USD Million)
6.3 Biotechnology
6.3.1 Biotechnology Market, 2018 – 2030 (USD Million)
Chapter 7 Small Molecule Innovators CDMO Market: Therapeutic Area Segment Analysis
7.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
7.2 Cardiovascular Disease
7.2.1 Cardiovascular diseases market, 2018 – 2030 (USD Million)
7.3 Oncology
7.3.1 Oncology market, 2018 – 2030 (USD Million)
7.4 Respiratory Disorders
7.4.1 Respiratory disorders market, 2018 – 2030 (USD Million)
7.5 Neurology
7.5.1 Neurology market, 2018 – 2030 (USD Million)
7.6 Metabolic Disorders
7.6.1 Metabolic disorders market, 2018 – 2030 (USD Million)
7.7 Infectious Diseases
7.7.1 Infectious diseases market, 2018 – 2030 (USD Million)
7.8 Others
7.8.1 Others market, 2018 – 2030 (USD Million)
Chapter 8 Small Molecule Innovators CDMO Market: Regional Analysis
8.1 Small Molecule Innovators CDMO: Market Share Analysis, 2023 & 2030
8.2 North America
8.2.1 North America Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3 Europe
8.3.1 Europe Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.2 UK
8.3.2.1 UK Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.4 France
8.3.4.1 France Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.7 Denmark
8.3.7.1 Denmark Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.8 Sweden
8.3.8.1 Sweden Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.3.9 Norway
8.3.9.1 Norway Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.2 India
8.4.2.1 India Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.4 China
8.4.4.1 China Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.4.7 Thailand
8.4.7.1 Thailand Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.6 MEA
8.6.1 MEA Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
8.6.5 Kuwait
8.6.5.1 Kuwait Small Molecule Innovators CDMO market, 2018 – 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Lonza
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Service benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Patheon (Thermo Fisher Scientific)
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Service benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Cambrex Corporation
9.1.3.1 Company overview
9.1.3.2 Service benchmarking
9.1.3.3 Strategic initiatives
9.1.4 Catalent, Inc
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Service benchmarking
9.1.5 Siegfried Holding AG
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Service benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Recipharm AB
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Service benchmarking
9.1.6.4 Strategic initiatives
9.1.7 CordenPharma International
9.1.7.1 Company overview
9.1.7.2 Service benchmarking
9.1.7.3 Strategic initiatives
9.1.8 Boehringer ingelheim
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Service benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Piramal Pharma Solutions
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Service benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Labcorp Drug Development
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Service benchmarking
9.1.10.4 Strategic initiatives
9.2 Company Analysis
9.2.1 Heat Map Analysis of Competitors

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 4. Global Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 5. Global Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 6. Global Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 7. Global Small Molecule Innovator CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 8. North America Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 9. North America Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 10. North America Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 11. North America Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 12. North America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 13. U.S. Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 14. U.S. Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 15. U.S. Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 16. U.S. Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 17. Canada Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 18. Canada Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 19. Canada Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 20. Canada Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 21. Europe Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 22. Europe Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 23. Europe Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 24. Europe Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 25. Europe Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 26. Germany Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 27. Germany Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 28. Germany Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 29. Germany Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 30. UK Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 31. UK Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 32. UK Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 33. UK Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 34. France Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 35. France Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 36. France Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 37. France Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 38. Italy Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 39. Italy Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 40. Italy Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 41. Italy Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 42. Spain Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 43. Spain Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 44. Spain Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 45. Spain Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 46. Denmark Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 47. Denmark Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 48. Denmark Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 49. Denmark Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 50. Sweden Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 51. Sweden Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 52. Sweden Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 53. Sweden Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 54. Norway Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 55. Norway Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 56. Norway Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 57. Norway Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 58. Asia Pacific Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 59. Asia Pacific Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 60. Asia Pacific Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 61. Asia Pacific Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 62. Asia Pacific Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 63. China Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 64. China Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 65. China Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 66. China Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 67. Japan Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 68. Japan Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 69. Japan Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 70. Japan Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 71. India Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 72. India Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 73. India Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 74. India Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 75. South Korea Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 76. South Korea Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 77. South Korea Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 78. South Korea Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 79. Australia Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 80. Australia Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 81. Australia Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 82. Australia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 83. ThailandSmall Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 84. ThailandSmall Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 85. ThailandSmall Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 86. ThailandSmall Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 87. Latin America Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 88. Latin America Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 89. Latin America Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 90. Latin America Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 91. Latin America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 92. Brazil Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 93. Brazil Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 94. Brazil Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 95. Brazil Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 96. Mexico Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 97. Mexico Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 98. Mexico Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 99. Mexico Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 100. Argentina Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 101. Argentina Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 102. Argentina Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 103. Argentina Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 104. Middle East & Africa Small Molecule Innovator CDMO Market, by Country, 2018 - 2030 (USD Million)
Table 105. Middle East & Africa Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 106. Middle East & Africa Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 107. Middle East & Africa Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 108. Middle East & Africa Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 109. South Africa Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 110. South Africa Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 111. South Africa Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 112. South Africa Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 113. Saudi Arabia Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 114. Saudi Arabia Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 115. Saudi Arabia Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 116. Saudi Arabia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 117. UAE Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 118. UAE Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 119. UAE Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 120. UAE Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 121. Kuwait Small Molecule Innovator CDMO Market, by Product, 2018 - 2030 (USD Million)
Table 122. Kuwait Small Molecule Innovator CDMO Market, by Stage Type, 2018 - 2030 (USD Million)
Table 123. Kuwait Small Molecule Innovator CDMO Market, by Customer Type, 2018 - 2030 (USD Million)
Table 124. Kuwait Small Molecule Innovator CDMO Market, by Therapeutic Area, 2018 - 2030 (USD Million)

※본 조사보고서 [세계의 저분자 이노베이터 CDMO 시장 2024-2030 : 제품별 (저분자 API, 저분자 의약품), 단계별, 고객 유형별, 치료 영역별, 지역별] (코드 : GRV24JAN134) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 저분자 이노베이터 CDMO 시장 2024-2030 : 제품별 (저분자 API, 저분자 의약품), 단계별, 고객 유형별, 치료 영역별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 저분자 이노베이터 CDMO 시장 (2023~2030) : 저분자 원료 의약품, 저분자 의약품 제품
GRV23MR035 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 저분자 이노베이터 CDMO 시장 규모가 2023년부터 2030년 사이에 CAGR 6.4% 증가하여, 2030년에는 749억 달러에 이를 것으로 전망하고 있습니다. 본 자료는 세계의...Small Molecule Innovator CDMO Market Growth & Trends The global small molecule innovator CDMO market size is expected to reach USD 74.9 billion by 2030, expanding at 6.4% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. There is a growing interest among pharmaceutical...

세계의 저분자 이노베이터 API CDMO 시장 2024-2030 : 전임상, 임상, 상업용
GRV24MAY092 / Grand View Research / 2024년 4월 / 글로벌 저분자 이노베이터 API CDMO시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 저분자 이노베이터 API CDMO 시장 규모는 2024년부터 2030년까지 연평균 6. 53% 성장하여 2030년까지 471억 4000만...1. 조사 방법 및 범위 2. 개요 3. 세계의 저분자 이노베이터 API CDMO 시장 변수, 동향 및 범위 4. 세계의 저분자 이노베이터 API CDMO 시장 단계별 예측 및 동향 분석 5. 세계의 저분자 이노베이터 API CDMO 시장 고객 유형별 예측 및 동향 분석 6. 세계의 저분자 이노베이터 API CDMO 시장...

글로벌 핵산 치료제 CDMO 시장 (2023-2030) : 프로세스 개발 및 최적화, 제조 서비스
GRV23NOV219 / Grand View Research / 2023년 9월 / 글로벌 핵산 치료제 CDMO 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 핵산 치료제 CDMO 시장 규모는 2023년부터 2030년까지 연평균 9. 4%의 성장률을 보이며 2030년에는 224억 2000만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 핵산 치료제 CDMO 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 핵산 치료제 CDMO 시장 : 서비스별 예측 및 동향 분석 Chapter 6. 세계의 핵산 치료제 CDMO 시장 : 최종...

글로벌 원료 의약품 CDMO 시장 (2023-2030) : 강력한 API, 항체 약물 접합체
GRV23NOV025 / Grand View Research / 2023년 9월 / 글로벌 원료 의약품 CDMO 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 원료 의약품 CDMO 시장 규모는 2030년까지 1,563억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 6....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 원료 의약품 CDMO 시장 : 제품별 분석 Chapter 5. 세계의 원료 의약품 CDMO 시장 : 합성별 분석 Chapter 6. 세계의 원료 의약품 CDMO 시장 : 약물별 분석 Chapter 7. 세계의 원료 의약품 CDMO 시장...

글로벌 재조합 단백질 치료제 CDMO 시장 (2023-2030) : 성장 호르몬, 인터페론, 백신, 면역 자극제
GRV23NOV236 / Grand View Research / 2023년 9월 / 글로벌 재조합 단백질 치료제 CDMO 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 재조합 단백질 치료제 CDMO 시장 규모는 2030년까지 519억 5000만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 재조합 단백질 치료제 CDMO 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 재조합 단백질 치료제 CDMO 시장 : 공급원별 예측 및 동향 분석 Chapter 6. 세계의 재조합 단백질 치료제 CDMO...